Randomized Trial of Ticagrelor for Severe Community Acquired Pneumonia

Trial Profile

Randomized Trial of Ticagrelor for Severe Community Acquired Pneumonia

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Community-acquired pneumonia
  • Focus Therapeutic Use
  • Acronyms TCAP
  • Most Recent Events

    • 10 Mar 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 05 Aug 2014 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top